MedTrace Logo

Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial

NCT00907543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2019-03-06

No results posted yet for this study

Summary

The purpose of this study is to compare the results of preoperative chemotherapy and radiation followed by surgery to surgery followed by postoperative chemotherapy and radiation for esophageal cancer.

Conditions

  • Esophageal Neoplasms

Interventions

OTHER

Preoperative treatment of chemotherapy and radiation

Cisplatin + 5FU with concurrent radiation followed by surgery

OTHER

Postoperative treatment of chemotherapy and radiation

Surgery followed by cisplatin + 5FU + epirubicin as indicated by pathological stage with extended beam radiation

Sponsors & Collaborators

  • Richard Malthaner

    lead OTHER

Principal Investigators

  • Richard Malthaner, MD · London Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00907543 on ClinicalTrials.gov